Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 5/20 | 0.33 |
| ▸ | CDK9 | P50750 | 5/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | FPR2 | P25090 | 1/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3298700 | 0.92 | CCNT1 (0.37) | CCNT1CDK9HDAC1NPY5RMAPT | |
| SCHEMBL14536807 | 0.89 | NPY5R (0.36) | CCNT1CDK9HDAC1NPY5RMAPT | |
| SCHEMBL13780011 | 0.84 | HDAC1 (0.39) | CCNT1CDK9HDAC1NPY5RMAPT | |
| SCHEMBL14536648 | 0.81 | HDAC1 (0.40) | CCNT1CDK9HDAC1NPY5RMAPT | |
| SCHEMBL13444573 | 0.81 | NPY5R (0.32) | CCNT1CDK9HDAC1NPY5R | |
| SCHEMBL13780008 | 0.79 | CCNT1 (0.40) | CCNT1CDK9HDAC1NPY5RMAPT | |
| SCHEMBL12716702 | 0.78 | CCNT1 (0.34) | CCNT1CDK9HDAC1NPY5RMAPT | |
| SCHEMBL10042625 | 0.78 | NPSR1 (0.35) | CCNT1CDK9HDAC1MEN1KMT2A | |
| SCHEMBL13779995 | 0.78 | NPY5R (0.31) | CCNT1CDK9NPY5R | |
| SCHEMBL13242783 | 0.77 | LMNA (0.39) | CCNT1CDK9NPY5RMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100187511-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100187511-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | TYR, DDC, OCIAD2 | CCNT1 1272/4885CDK9 1108/4885HDAC1 2366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.